Ludwig Hantson
2018
In 2018, Ludwig Hantson earned a total compensation of $16.5M as Chief Executive Officer at Alexion Pharmaceuticals, a 8% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $2,880,000 |
|---|---|
| Salary | $1,200,000 |
| Stock Awards | $12,385,168 |
| Other | $25,082 |
| Total | $16,490,250 |
Hantson received $12.4M in stock awards, accounting for 75% of the total pay in 2018.
Hantson also received $2.9M in non-equity incentive plan, $1.2M in salary and $25.1K in other compensation.
Rankings
In 2018, Ludwig Hantson's compensation ranked 264th out of 14,244 executives tracked by ExecPay. In other words, Hantson earned more than 98.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 264 out of 14,244 | 98th |
Division Manufacturing | 87 out of 5,759 | 99th |
Major group Chemicals And Allied Products | 29 out of 2,122 | 99th |
Industry group Drugs | 24 out of 1,811 | 99th |
Industry Pharmaceutical Preparations | 17 out of 1,385 | 99th |
Source: SEC filing on March 26, 2019.
Hantson's colleagues
We found five more compensation records of executives who worked with Ludwig Hantson at Alexion Pharmaceuticals in 2018.
2018
Julie O'Neill
Alexion Pharmaceuticals
Former Executive Vice President of Global Operations
2018
Paul Clancy
Alexion Pharmaceuticals
Chief Financial Officer
2018
Anne-Marie Law
Alexion Pharmaceuticals
Executive Vice President, Chief Patient and Employee Experience Officer
2018
Brian Goff
Alexion Pharmaceuticals
Executive Vice President and Chief Commercial Officer
2018
John Orloff
Alexion Pharmaceuticals